Cargando…

1172. Mucormycosis Treated with Isavuconazole: A matched-Pair Analysis from the FungiScope(®) Registry

BACKGROUND: Isavuconazole (ISAV) is a novel, broad-spectrum triazole antifungal, available in both intravenous and oral formulations, for the treatment of adult patients with invasive aspergillosis or mucormycosis. In this retrospective case collection study, we compared outcomes for patients with i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seidel, Danila, Cornely, Oliver, Vehreschild, Maria J G T, Koehler, Philipp, Salmanton-García, Jon, Klimko, Nikolay, Herbrecht, Raoul, Heinemann, Melina, Prattes, Jürgen, Schalk, Enrico, Miceli, Marisa H, Ráčil, Zdeněk, Falces-Romero, Iker, Hoenigl, Martin, Kessel, Johanna, Bertz, Hartmut, Novak, Jan, Wisplinghoff, Hilmar, Barmaki-Rad, Farima, Saulay, Mikael, Engelhardt, Marc, Hamed, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777167/ http://dx.doi.org/10.1093/ofid/ofaa439.1358

Ejemplares similares

2046. FungiScope™: News on the Global Emerging Fungal Infection Registry
por: Seidel, Danila, et al.
Publicado: (2018)

Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(®) registry
por: Sal, Ertan, et al.
Publicado: (2022)

403. Prognostic Factors in 260 Adults With Invasive Scedosporiosis From Literature and FungiScope™
por: Seidel, Danila, et al.
Publicado: (2018)

Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope(®) registry and literature reports
por: Sprute, Rosanne, et al.
Publicado: (2020)

Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope(®) and the literature
por: Sprute, Rosanne, et al.
Publicado: (2021)

2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2019)

2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study
por: Seidel, Danila, et al.
Publicado: (2019)

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018)

Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases
por: Kaindl, Thomas, et al.
Publicado: (2019)

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system
por: Schwartz, Stefan, et al.
Publicado: (2020)

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
por: Zurl, Christoph, et al.
Publicado: (2020)

1149. Baseline Chest CT Findings in Patients with Pulmonary Mold Infections: A Post-Hoc Analysis from the Phase 3 SECURE Study that Compared Isavuconazole to Voriconazole for the Primary Treatment of Invasive Mold Disease
por: Hamed, Kamal, et al.
Publicado: (2020)

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
por: Thompson, George R., et al.
Publicado: (2016)

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
por: Salmanton-García, Jon, et al.
Publicado: (2021)

1568. Implementation of a Standard Diet Regimen for Neutropenic High-Risk Cancer Patients: Effects on Incidence of Infections, Foodborne Diseases, and Outcome
por: Jakob, Carolin, et al.
Publicado: (2018)

1172. SARS-CoV-2 Vaccine Hesitancy in Caregivers of Hospitalized Children
por: Orbea, Marisa, et al.
Publicado: (2021)

618. The current state of laboratory mycology in Asia/Pacific: a survey from the EuropeanConfederation of Medical Mycology (ECMM) and International Society for Human andAnimal Mycology (ISHAM)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

617. Laboratory capacities to diagnose and treat Invasive Fungal Infections in Europe: results from an ECMM survey
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

P1607: EPICOVIDEHA KIDS: A READY TO USE PLATFORM FOR EPIDEMIOLOGICAL STUDIES IN PEDIATRIC HEMATOLOGICAL PATIENTS WITH COVID-19
por: Salmanton-García, J., et al.
Publicado: (2022)

Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection—A Prospective Pilot Study
por: Koehler, Felix C., et al.
Publicado: (2018)

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
por: Perfect, John R., et al.
Publicado: (2018)

Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole
por: Kovanda, Laura L., et al.
Publicado: (2017)

Effectiveness of the Laser Application in Temporomandibular Joint Disorder: A Systematic Review of 1172 Patients
por: Zwiri, Abdalwhab, et al.
Publicado: (2020)

1172. Compliance with Human Papillomavirus Vaccination At The HIV Outpatient Program in New Orleans, Louisiana
por: Yau, Tat, et al.
Publicado: (2023)

1598. Clinical implications of azole-resistant vs. azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) – a multicenter study
por: Seidel, Danila, et al.
Publicado: (2020)

Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
por: Marty, Francisco M., et al.
Publicado: (2014)

1172. Travel-Associated Multidrug-Resistant Organism Acquisition and Risk Factors Among US Military Personnel
por: Buchek, Gregory, et al.
Publicado: (2018)

Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016)

Posaconazole and isavuconazole induced hypomagnesaemia
por: Burston, John, et al.
Publicado: (2018)

Isavuconazole for invasive fungal infections
Publicado: (2020)

2110. Treatment of Coccidioidomycosis with Isavuconazole
por: Jamros, Christina, et al.
Publicado: (2019)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
por: Elhence, Hirsh, et al.
Publicado: (2022)

P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
por: Salmanton-García, Jon, et al.
Publicado: (2023)

E15.5 Mouse Embryo Micro-CT Using a Bruker Skyscan 1172 Micro-CT
por: Astanina, Elena, et al.
Publicado: (2023)

P1172: ARTIFICIAL INTELLIGENCE FOR PROGNOSIS PREDICTION OF NATURAL KILLER/T-CELL LYMPHOMA BASED ON MAGNETIC RESONANCE IMAGING
por: Cai, Qingqing, et al.
Publicado: (2023)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021)

393. Isavuconazole in the Treatment of Coccidioidal Meningitis
por: Heidari, Arash, et al.
Publicado: (2018)

Isavuconazole Kinetic Exploration for Clinical Practice
por: Darnaud, Léa, et al.
Publicado: (2018)

Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
por: Ilharco, Marta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_42np4sfobspmdgfa159nr0sfd1